Dan Karlin is the Head of Clinical, Informatics, and Regulatory Strategy for Digital Medicine and the Pfizer Innovation Research Lab, where he manages strategy for multiple aspects of Pfizer’s collaborative digital development efforts. This team ensures that asset teams have access to and an understanding of the value that these digital efforts bring to the clinical development paradigm. He is active in the mobile sensing space, investigating technologies, their applicability to drug development, and rational pathways for their validation and integration. He develops and executes strategies for data management, analysis, and interpretation for projects and programs throughout the company. Dan is board certified in Psychiatry, Clinical Informatics, and Addiction Medicine and also serves as an Assistant Professor of Psychiatry at Tufts University School of Medicine. Dan received his BA in Neuroscience and his MA in Medical Informatics from Columbia University; his MD from the University of Colorado School of Medicine; and trained in psychiatry at Tufts Medical Center.